SPOTLIGHT -
Going Beyond the Headlines on Health Spending in 4 Steps
Health care spending in the United States is at the center of a loud, fractured debate mired in deep complexity.
Read More
Aiming for Value Over Volume in Cancer Drug Spending
Several groups have developed value assessment frameworks that consider the value of new treatments, yet most models fall short balancing the evaluation of treatment costs with the consideration of benefits to the patient.
Having a Broader Conversation About Healthcare Spending
Healthcare stakeholders must evaluate how to use resources more efficiently as it has become clear that driving down prices in one segment of care has not improved medical outcomes for the majority of patients.
Working Toward Better Value in Prescription Drug Benefits Management
Many healthcare stakeholders are concerned that pharmacy benefit managers use perverse incentives that work against healthcare goals, such as improved outcomes and lower costs.
Guiding Practices for Patient-Centered Value Assessment
Physician-, payer-, and patient-based organizations are increasingly developing frameworks that measure the value of a treatment and define it in terms of specific target audiences.
Value Depends on Real-World Evidence
Healthcare stakeholders must work with regulators and policy makers to reduce barriers that prevent the alignment of a drug’s value and price.
